SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-118148
Filing Date
2020-04-24
Accepted
2020-04-24 07:32:34
Documents
5
Period of Report
2020-06-09
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d918573ddef14a.htm DEF 14A 306034
2 GRAPHIC g918573g42n10.jpg GRAPHIC 21392
3 GRAPHIC g918573g78a96.jpg GRAPHIC 44533
4 GRAPHIC g918573img001.jpg GRAPHIC 162002
5 GRAPHIC g918573img002.jpg GRAPHIC 131418
  Complete submission text file 0001193125-20-118148.txt   801827
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37490 | Film No.: 20812486
SIC: 2834 Pharmaceutical Preparations